openPR Logo
Press release

Digital Therapeutics Market to Reach US$ 39.52 Billion by 2033 at 21.6% CAGR - North America Leads with 42% Share | Livongo, Medtronic, Omada Health

12-16-2025 06:10 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Digital Therapeutics Market

Digital Therapeutics Market

The Global Digital Therapeutics Market reached US$ 6.84 billion in 2024 and is expected to reach US$ 39.52 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2025-2033. The market is expanding rapidly as healthcare systems increasingly adopt software-driven, evidence-based interventions for disease prevention, management, and treatment, particularly for chronic and lifestyle-related conditions.

Digital therapeutics leverage software and connected devices to deliver clinically validated therapies through flexible service models, ranging from fully integrated platforms that combine hardware, software, and clinical support to modular Software-as-a-Service solutions. This adaptability supports broad adoption among payers, healthcare providers, and patients. Market momentum is reinforced by continuous innovation and product launches; for example, in April 2025, Teladoc Health introduced its Next Generation Cardiometabolic Health Program aimed at improving population health and slowing the progression of obesity, diabetes, and hypertension, highlighting the growing role of digital therapeutics in transforming chronic disease management and healthcare delivery.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/digital-therapeutics-market?sai-v

The digital therapeutics market is the sector that delivers evidence-based therapeutic interventions through software and digital platforms to prevent, manage, or treat medical conditions.

Key Developments
✅ December 2025: Healthcare providers expanded adoption of prescription digital therapeutics platforms to support chronic disease management, mental health care, and behavioral therapy through evidence-based software interventions.

✅ October 2025: Digital therapeutics companies enhanced platforms with AI-driven personalization, real-time patient monitoring, and adaptive treatment pathways to improve clinical outcomes and adherence.

✅ August 2025: Integration of digital therapeutics with electronic health records (EHRs) and remote patient monitoring systems improved clinician oversight and data-driven decision-making.

✅ June 2025: Growing acceptance of digital therapeutics by payers and employers accelerated deployment of app-based treatments for diabetes, cardiovascular conditions, and substance use disorders.

✅ March 2025: Clinical trials and regulatory submissions increased for software-as-a-medical-device (SaMD) solutions targeting neurological, respiratory, and metabolic disorders.

Mergers & Acquisitions
✅ December 2025: A leading digital health company acquired a digital therapeutics startup to expand its portfolio of regulated, evidence-based treatment solutions.

✅ October 2025: Strategic partnerships were formed between digital therapeutics developers and pharmaceutical companies to combine drug therapies with software-driven patient support programs.

✅ August 2025: Digital therapeutics firms collaborated with healthcare providers to deploy condition-specific digital treatment pathways at scale.

✅ June 2025: Technology companies entered alliances with insurers to support reimbursement and broader adoption of prescription digital therapeutics.

✅ March 2025: Industry participants partnered with academic and research institutions to validate clinical efficacy and strengthen regulatory compliance of digital therapeutics solutions.

Key Players
2Morrow Inc. | Livongo Health, Inc. | Medtronic Plc. | Omada Health, Inc. | Pear Therapeutics, Inc. | Proteus Digital Health, Inc. | ResMed, Inc. (Propeller Health) | Voluntis, Inc. | Welldoc, Inc.

Key Highlights
2Morrow Inc. - Holds a share of 13.6%: Specializes in evidence-based digital behavior change programs for smoking cessation, stress management, and chronic disease prevention.

Livongo Health, Inc. - Holds a share of 15.2%: Leads the market with AI-driven chronic condition management platforms, real-time health insights, and strong employer and payer adoption.

Medtronic Plc. - Holds a share of 14.4%: Leverages connected medical devices and digital therapeutics to support diabetes, cardiac, and chronic disease management at scale.

Omada Health, Inc. - Holds a share of 12.1%: Focuses on virtual care programs for diabetes prevention, weight management, and cardiometabolic health with proven clinical outcomes.

Pear Therapeutics, Inc. - Holds a share of 10.3%: Known for FDA-authorized prescription digital therapeutics targeting substance use disorders and mental health conditions.

Proteus Digital Health, Inc. - Holds a share of 9.2%: Develops ingestible sensors and digital medicine platforms to improve medication adherence and patient monitoring.

ResMed, Inc. (Propeller Health) - Holds a share of 8.5%: Strong presence in respiratory digital health through connected inhalers and data-driven asthma and COPD management solutions.

Voluntis, Inc. - Holds a share of 7.4%: Provides therapeutic companion software supporting oncology and chronic disease patients with personalized treatment guidance.

Welldoc, Inc. - Holds a share of 9.3%: Delivers FDA-cleared digital therapeutics for diabetes and cardiometabolic conditions using AI-powered coaching and clinical decision support.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=digital-therapeutics-market?sai-v
(Purchase 2 or more Reports and get 50% discount)

Market Drivers
- Rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and mental health conditions.

- Growing adoption of mobile health applications and digital healthcare platforms.

- Increasing demand for personalized, data-driven, and remote treatment solutions.

- Expansion of telehealth and virtual care services globally.

- Advancements in AI, machine learning, and behavioral analytics enabling effective digital interventions.

- Supportive regulatory frameworks and growing clinical validation of digital therapeutics.

- Increasing focus on cost-effective healthcare delivery and improved patient outcomes.

Industry Developments
- Launch of prescription-based digital therapeutics for diabetes, mental health, and chronic disease management.

- Expansion of clinical trials to validate the efficacy of digital therapeutic solutions.

- Growing partnerships between digital therapeutics companies and healthcare providers.

- Integration of digital therapeutics with wearable devices and remote patient monitoring systems.

- Development of AI-driven platforms for personalized therapy and treatment adherence.

- Increasing reimbursement coverage for approved digital therapeutic products.

- Rising investment and acquisitions in the digital therapeutics ecosystem.

Regional Insights
North America - 42% share: "Driven by strong digital health adoption, supportive reimbursement policies, and high prevalence of chronic diseases."

Europe - 28% share: "Supported by growing regulatory clarity, increasing telehealth usage, and strong public healthcare systems."

Asia Pacific - 25% share: "Fueled by rapid digitalization, expanding smartphone penetration, and rising demand for remote healthcare solutions."

Latin America - 3% share: "Boosted by improving digital healthcare infrastructure and growing interest in virtual care platforms."

Middle East & Africa - 2% share: "Driven by increasing investments in digital health, telemedicine adoption, and healthcare modernization initiatives."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/digital-therapeutics-market?sai-v

Key Segments

➥ By Product Type
Software: Digital platforms and applications delivering evidence-based interventions, monitoring, analytics, and personalized therapeutic content.

Devices: Connected medical devices and wearables used to track patient data, support therapy delivery, and enhance treatment adherence.

Others: Includes hybrid solutions, accessories, and supporting technologies integrated with digital therapeutic ecosystems.

➥ By Application
Diabetes: Digital therapeutics designed for glucose monitoring, lifestyle management, medication adherence, and patient education.

Obesity: Solutions focused on weight management through behavioral therapy, nutrition guidance, and activity tracking.

Cardiovascular Diseases (CVD): Platforms supporting cardiac monitoring, risk management, and lifestyle modification to improve heart health.

Central Nervous System (CNS) Diseases: Digital interventions addressing neurological and mental health conditions such as depression, anxiety, and neurological disorders.

Respiratory Diseases: Applications supporting disease monitoring, symptom tracking, and treatment adherence for respiratory conditions.

Smoking Cessation: Behavior-change programs designed to help users quit smoking through coaching, monitoring, and motivational support.

Gastrointestinal Disorders (GID): Digital solutions aiding symptom tracking, dietary management, and patient engagement for digestive health.

Others: Includes applications in oncology, musculoskeletal disorders, women's health, and additional therapeutic areas.

➥ By Sales Channel
Business-to-Business (B2B): Solutions marketed to employers, healthcare providers, payers, and pharmaceutical companies for population health management and clinical support.

Business-to-Consumer (B2C): Direct-to-patient and caregiver sales models offering personalized digital therapeutics through apps and connected devices.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Therapeutics Market to Reach US$ 39.52 Billion by 2033 at 21.6% CAGR - North America Leads with 42% Share | Livongo, Medtronic, Omada Health here

News-ID: 4316188 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Biorefinery Market to Reach US$ 398.15 Billion by 2032 at 8.2% CAGR - North America Leads with 36% Share | Key Players: Neste, TotalEnergies, Cargill
Biorefinery Market to Reach US$ 398.15 Billion by 2032 at 8.2% CAGR - North Amer …
The Global Biorefinery Market reached US$ 211.95 billion in 2024 and is expected to reach US$ 398.15 billion by 2032, growing at a CAGR of 8.2% during the forecast period 2025-2032. The market is expanding steadily due to rising global energy demand driven by population growth and increasing concerns over climate change caused by escalating greenhouse gas emissions. Market growth is supported by the growing need for sustainable and renewable alternatives
Refrigerated Warehousing Market is growing at a CAGR of 17.9%, led by Asia-Pacific 39% of global market share| Key Players:- Trenton Cold Storage, Lineage Logistics Holdings LLC, Americold
Refrigerated Warehousing Market is growing at a CAGR of 17.9%, led by Asia-Pacif …
The global Refrigerated warehousing market size was valued at USD 85.35 billion in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 17.9% from 2023 to 2030. The market is driven by factors such as growing consumption of frozen foods and changing consumer preferences. Moreover, the growing adoption of automation in refrigerated warehouses is boosting market growth. A refrigerated warehouse is a space or building
Fuel Cell for Aircraft Market Poised for Rapid Growth at 24.5% CAGR Through 2031 - Europe Holds 34% Share | Airbus, Honeywell, Collins Aerospace
Fuel Cell for Aircraft Market Poised for Rapid Growth at 24.5% CAGR Through 2031 …
The Global Fuel Cell for Aircraft Market reached US$ 178.3 million in 2022 and is expected to reach US$ 1,097.0 million by 2031, growing at a CAGR of 24.5% during the forecast period 2024-2031. The market is witnessing rapid growth as the aviation industry increasingly focuses on reducing carbon emissions and adopting cleaner propulsion technologies. Market expansion is driven by rising investments in sustainable aviation, advancements in hydrogen fuel cell technology,
Care Management Solutions Market Set for Strong Growth to USD 22.1 Billion by 2030, Led by North America's 36.7% Global Market Share | DataM Intelligence
Care Management Solutions Market Set for Strong Growth to USD 22.1 Billion by 20 …
The Global Care Management Solutions Market reached USD 12.6 billion in 2022 and is expected to reach USD 22.1 billion by 2030, growing at a strong CAGR of 11.5% during 2024-2031. Market growth is driven by increasing prevalence of chronic diseases, rising demand for coordinated and value-based healthcare, and growing adoption of digital health platforms. Additionally, advancements in healthcare IT, expanding use of population health management tools, and the push to

All 5 Releases


More Releases for Digital

Digital luxury brands Market Is Booming Worldwide | Major Giants Balenciaga Digi …
HTF MI recently introduced Global Digital luxury brands Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major companies in Digital luxury brands Market are: Balenciaga Digital, Louis Vuitton Digital, Gucci Digital, Dolce & Gabbana DGFamily, Prada Virtual,
Introducing Digital Sales Pro, Inc: Revolutionizing Digital Sales in the Digital …
Digital Sales Pro, Inc. is a company that helps content creators and publishers make money from content and reach a larger audience with their craft. In today's world, it can be tough for content creators and publishers to make money and connect with their audience. At, Digital Sales Pro, Inc. we understand these challenges and have created a suite of solutions that help our clients build a strong online presence, monetize
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
Introduction The healthcare industry has seen significant growth and development over the years, with technology playing a critical role in transforming patient care. One such innovative technology that has emerged in recent years is the Global Digital Twin in Healthcare Market. This technology allows healthcare professionals to create a virtual replica of a patient's physical self, enabling them to monitor and analyze patient data in real-time. The Global Digital Twin in
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
In 2021, the market for Digital Twin in Healthcare worldwide was worth $6.75 billion US dollars. AMR Group projects that the market will reach US$ 96.5 billion by 2031, growing at a CAGR of 40 percent between 2022 and 2031. Industry Overview Digital twins are virtual copies of physical objects or things that data scientist & IT professionals can use to compute simulations prior to developing and deploying the original devices. Digital
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Digital Display Market Future Growth with Worldwide Players (Digital Virgo, Digi …
Digital Display Industry 2019 Global Market 2025 research report represents the historical overview of current Market situation, size, share, trends, growth, supply, outlook and manufacturers with detailed analysis. It also focuses on Digital Display volume and value at global level, regional level and company level. From a global perspective, this report represents overall Digital Display market size by analyzing historical data and future prospect. Get Sample Copy of this Report -